Evaluation of host quality of life and immune function in breast cancer patients treated with combination of adjuvant chemotherapy and oral administration of Lentinula edodes mycelia extract

PURPOSE: Anthracycline-based chemotherapies for breast cancer are well known to have adverse effects and can also negatively affect host immune function. There is therefore a necessity for an adjuvant that maintains the quality of life (QOL) and immune function of cancer patients receiving anthracyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagashima, Yukiko, Maeda, Noriko, Yamamoto, Shigeru, Yoshino, Shigefumi, Oka, Masaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711972/
https://www.ncbi.nlm.nih.gov/pubmed/23874107
http://dx.doi.org/10.2147/OTT.S44169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711972/
https://www.ncbi.nlm.nih.gov/pubmed/23874107
http://dx.doi.org/10.2147/OTT.S44169

Ejemplares similares